Euro-Med Laboratories Phil., Inc. Approves Cash Dividend, Payable on 21 November 2022
October 19, 2022 at 05:54 am IST
Share
Euro-Med Laboratories Phil., Inc. announced that Board of Directors at its regular meeting held on 18 October 2022 in which a quorum was present throughout, unanimously approved the declaration of cash dividend in the amount of PHP 0.020 per share from the unrestricted retained earnings of the Corporation as of 31 December 2021, to all stockholders of record as of 04 November 2022 and which shall be paid on 21 November 2022.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 